Skip to content

Meet Ren

Ren

Ren's story

HRT Access Fund recipient

Ren (he/they) is currently facing significant barriers to accessing hormone replacement therapy (HRT).  Without health insurance to cover the cost of treatment, HRT feels out of reach. Ren is also unemployed, further complicating their ability to afford this essential aspect of their transition.

Receiving support for HRT would make a tremendous difference in Ren’s life, helping to cover the costs that are currently unattainable. Ren believes that accessing HRT would provide much-needed motivation, allowing them to feel more comfortable and confident in their body as they move forward with their transition.

Ren's timeline

  • Award Granted

    August 12, 2024

    Ren was awarded a grant toward HRT/GaHT!

Grant details

$1,450 towards gender-affirming care.





About Testosterone+

On average, it costs $1,200+/year for Ren's care.

What is it?

Testosterone+ refers to the gender-affirming hormone replacement therapy (HRT) methods that some trans men, trans masc, and non-binary people take that result in physical changes which align with their gender identity. Every person's preferences and personal healthcare needs vary, so this can include oral medications, injections, and transdermal patches.

How accessible is it for trans folks to receive this care?

For trans folks who live in states most impacted by anti-trans healthcare legislation, it can be extremely difficult to find a knowledgeable, trans-affirming provider as well as access prescription medication. Many insurance plans do not cover HRT. For trans folks without insurance coverage, the ongoing out-of-pocket expense can be challenging.

What is the impact of this care on the recipient’s life?

Testosterone+ introduces a wide range of masculinizing physical, emotional, and psychological changes that align with their gender identity. This often leads to a more positive emotional well-being, increased confidence, increased safety when in public, and better opportunities at employment and more.